Med-tech firms raising money in public or private financings, including: Polyrizon, Spectrum Vascular.

Biopharmas raising money in public or private financings, including: Calidi, DBV, Dermata, Eli Lilly, Isomorphic, Lomond, Maat, Novartis, Savara.

French biotech Pep-Therapy SAS is in the midst of raising a €20 million (US$21.62 million) round and, at the same time, prospecting for potential partners after winning FDA orphan drug designation for its bifunctional peptide Pep-010 in the treatment of pancreatic cancer. Pep-010 currently is moving to the conclusion of a phase Ib trial and the new money will fund phase II development.

Biopharmas raising money in public or private financings, including: Vivani.

Med-tech firms raising money in public or private financings, including: Hearflow, Owens & Minor, Owlstone.

Biopharmas raising money in public or private financings, including: Epicrispr, Hubble, Jaguar, Tribune.

Med-tech firms raising money in public or private financings, including: Supira Medical, Volitionrx.

Biopharmas raising money in public or private financings, including: Benitec, Character Biosciences, Cytonics, Genelux, Neuronos.